-+ 0.00%
-+ 0.00%
-+ 0.00%

Arbutus Biopharma shareholders approve 2026 omnibus share, incentive plan at annual meeting

PUBT·05/27/2026 20:04:42
Listen to the news
Arbutus Biopharma shareholders approve 2026 omnibus share, incentive plan at annual meeting
  • May 26, 2026 shareholder meeting adopted the 2026 Omnibus Share and Incentive Plan, replacing the 2011 and 2016 equity plans.
  • The plan authorizes issuance of up to 16,300,000 common shares; the vote reflects approval to adopt, not a confirmation of any awards.
  • Shareholders ratified Ernst & Young as independent registered public accounting firm for the fiscal year ending Dec. 31, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arbutus Biopharma Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001447028-26-000024), on May 27, 2026, and is solely responsible for the information contained therein.